First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

Detalles Bibliográficos
Autores principales: Evans, Manon, Guest, Ryan, Rothwell, Dominic, Burt, Debbie, Kirillova, Natalia, Haughton, Jennifer, Chow, Shien, Thistlethwaite, Fiona, Gilham, David, Hawkins, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288417/
http://dx.doi.org/10.1186/2051-1426-2-S3-P12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288417/
http://dx.doi.org/10.1186/2051-1426-2-S3-P12

Ejemplares similares